Cipla, Novartis team up to make, market anti-diabetic drug
HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.
Drugs
Pharma
Cipla’s board rejects plan to transfer US-based operations
HQ Team November 4, 2022: The management of Cipla, an Indian drug maker, has rejected a plan to transfer its US-based operations based.
Pharma
Cipla joins WEF’s ‘Lighthouse network’ to digitally transform operations
Cipla, an Indian pharmaceutical company, has joined the World Economic Forum’s Lighthouse network to adopt advanced fourth-industrial revolution technologies to transform operations digitally.